Global Pet Scanners Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By modality, the market includes different types of PET scanners, such as PET-CT and PET-MRI. PET-CT scanners combine the metabolic imaging capability of PET with the detailed anatomical imaging provided by CT, enabling healthcare professionals to obtain comprehensive diagnostic information for a range of applications, especially in oncology, cardiology, and neurology. This combination allows for precise tumor identification, treatment monitoring, and disease progression evaluation. On the other hand, PET-MRI scanners integrate PET with high-resolution MRI, which offers superior soft tissue contrast without the ionizing radiation associated with CT. This combination is valuable for imaging areas that require high detail, such as the brain and spinal cord, and is particularly advantageous in pediatric care and scenarios where reducing radiation exposure is critical. While PET-CT remains the more widely adopted modality due to its cost-effectiveness, PET-MRI is gaining traction in specialized areas that prioritize detailed soft tissue imaging.

In terms of application, the market for PET scanners spans various areas including oncology, neurology, cardiology, and other diagnostic fields. Oncology is the largest application area, with PET scanners playing a crucial role in detecting and staging cancers, monitoring treatment response, and assessing metastatic spread. Neurology also represents a significant segment, with PET being used to evaluate brain function and diagnose conditions such as Alzheimer's disease, epilepsy, and other neurological disorders. Cardiology utilizes PET scanners for assessing heart function, detecting coronary artery disease, and evaluating myocardial viability. Other applications include research and development in disease mechanisms and experimental treatments, expanding the use of PET technology beyond standard clinical diagnostics.

The end-user segmentation includes hospitals, diagnostic imaging centers, academic and research institutes, and others. Hospitals are key users of PET scanners, providing comprehensive diagnostic and treatment planning services. Diagnostic imaging centers offer specialized imaging services and contribute to the market by expanding access to PET technology without the broader clinical services of a hospital. Academic and research institutes use PET scanners for research into disease treatment, drug development, and the study of complex biological processes. These institutions often collaborate with hospitals and industry partners to advance medical technology and improve diagnostic capabilities. Other end-users may include specialized clinics or facilities that cater to niche diagnostic services.

Geographically, the global pet scanners market is divided into regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads the market, driven by advanced healthcare infrastructure, high adoption rates of PET technologies, and strong research initiatives. Europe follows with robust healthcare systems and ongoing investments in medical imaging. The Asia-Pacific region is expected to see substantial growth due to rising healthcare expenditures, increasing awareness, and expanding access to medical imaging technologies. Latin America and the Middle East & Africa are also growing, with market expansion influenced by improving healthcare infrastructure and rising demand for diagnostic services. Each region has its unique challenges, including regulatory environments, economic conditions, and variations in healthcare access, which shape the growth and adoption of PET scanners.

Global Pet Scanners Segment Analysis

In this report, the global pet scanners market has been segmented by Modality, Application, End User, and Geography.

Global Pet Scanners Market, Segmentation by Modality

The Global Pet Scanners Market has been segmented by Modality into PET-CT and PET-MRI.

PET-CT, or positron emission tomography-computed tomography, combines the functional imaging capability of PET with the detailed anatomical imaging provided by CT. This combination allows healthcare professionals to assess both metabolic and structural information, making it particularly valuable for oncology, cardiology, and neurology applications. PET-CT has established itself as the standard for many clinical practices due to its ability to accurately identify tumors, assess their metabolic activity, and map their precise location within the body. This modality is widely used for diagnosing various types of cancers, monitoring treatment progress, and evaluating responses to therapy. The integration of PET and CT technologies offers improved patient care by enabling earlier detection and more precise treatment planning.

PET-MRI, or positron emission tomography-magnetic resonance imaging, merges the PET's metabolic imaging with the high-resolution soft tissue imaging provided by MRI. While PET-MRI is not as widely adopted as PET-CT, it is gaining traction for specific clinical scenarios, especially in fields requiring detailed soft tissue evaluation, such as neurology, oncology, and musculoskeletal imaging. The advantage of PET-MRI lies in its superior soft tissue contrast, which is critical for accurate diagnosis and treatment of conditions involving the brain, spinal cord, and other soft tissues. Additionally, PET-MRI avoids ionizing radiation associated with CT, making it a preferable option for certain patient groups, such as pediatric and younger patients, where minimizing radiation exposure is essential. The combination of these technologies provides an enhanced imaging experience, offering both functional and detailed structural information with potentially lower radiation doses compared to PET-CT.

Global Pet Scanners Market, Segmentation by Geography

In this report, the Global Pet Scanners Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Pet Scanners Market Share (%), by Geographical Region, 2024

North America has emerged as a dominant force in the global PET scanner market, boasting a substantial revenue share of 34.20% in 2022. This leadership position can be attributed to a convergence of factors, chief among them being the rapid technological advances in the diagnostic and medical imaging sector within the region. North America is home to numerous pioneering companies and research institutions at the forefront of PET scanner innovation, continually pushing the boundaries of what these diagnostic tools can achieve. These technological advancements not only improve the accuracy and efficiency of PET scanning but also drive down costs, making these devices more accessible to a wider range of healthcare providers and patients across the continent.

Moreover, North America's position as a leader in the global PET scanner market is reinforced by the significant strides made in healthcare infrastructure and facilities throughout the region. The United States and Canada, in particular, have invested heavily in expanding and modernizing their healthcare systems, resulting in a network of world-class hospitals, clinics, and imaging centers equipped with state-of-the-art diagnostic technologies. This advanced healthcare infrastructure enables healthcare professionals in North America to leverage PET scanners effectively for early disease detection, precise treatment planning, and monitoring patient response to therapy. As a result, the region continues to attract substantial investments from both domestic and international players in the PET scanner market, further solidifying its dominant position on the global stage.

This report provides an in depth analysis of various factors that impact the dynamics of Global Pet Scanners Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunities Analysis

Drivers:

• Advancements in Technology
• Growing Pet Ownership

• Awareness of Pet Health - Pet owners are increasingly recognizing the importance of regular health check-ups and preventive care for their animals, a trend that is significantly influencing the veterinary industry. This heightened awareness is driven by several factors, including increased access to information through the internet and social media, which educates pet owners about the benefits of early disease detection and ongoing health monitoring. Additionally, veterinarians and pet advocacy organizations are actively promoting the importance of routine health screenings and preventive measures, emphasizing how these practices can lead to longer, healthier lives for pets. As a result, more pet owners are seeking comprehensive veterinary care, including diagnostic services that can detect potential health issues before they become serious.

  This growing demand for diagnostic services and equipment is having a substantial impact on the veterinary market, particularly in terms of the types of technologies and services that are being prioritized. Veterinary clinics are increasingly investing in advanced diagnostic tools such as pet scanners, which include ultrasound, MRI, CT scans, and X-rays, to meet the needs of informed pet owners. These technologies enable more accurate and timely diagnosis of a wide range of conditions, from internal injuries and infections to chronic diseases like arthritis and cancer. The willingness of pet owners to invest in the health of their animals is also driving the expansion of veterinary diagnostic services, leading to the establishment of more specialized clinics and the integration of sophisticated diagnostic equipment into general practice. This trend not only enhances the quality of care that pets receive but also encourages ongoing innovation and development within the veterinary diagnostics market.

Restraints:

• High Initial Investment
• Lack of Skilled Professionals

• Regulatory Hurdles - The stringent regulatory requirements for medical devices, including pet scanners, pose significant challenges to market growth by slowing down the approval and distribution process. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce rigorous standards to ensure the safety, efficacy, and quality of veterinary diagnostic devices. These regulations require manufacturers to conduct extensive clinical trials, detailed documentation, and comprehensive testing before a pet scanner can be approved for market entry. This process, while essential for maintaining high safety standards, can be time-consuming and costly, often leading to delays in bringing new technologies to market. Consequently, companies may face prolonged timeframes and increased expenditures, which can hinder innovation and limit the availability of advanced diagnostic tools for veterinary care.

  Additionally, the complexity of navigating diverse regulatory environments across different regions can further complicate the approval and distribution process for pet scanners. Each country or region may have its own set of regulations and requirements, necessitating tailored strategies for compliance. For instance, a pet scanner approved in the United States might still need to undergo additional testing and approval procedures to meet the regulatory standards of the European Union or other markets. This fragmentation can lead to inconsistencies in the availability of pet scanners worldwide, potentially creating disparities in the quality of veterinary diagnostics across different regions. The need to invest in regulatory expertise and resources can also strain smaller companies, potentially stifling competition and innovation within the market. Despite these challenges, ongoing efforts to streamline regulatory processes and foster international cooperation aim to mitigate these barriers, ultimately supporting the growth and accessibility of advanced veterinary diagnostic technologies.

Opportunities:

• Technological Innovation
• Expansion into Emerging Markets

• Telemedicine Integration - The integration of pet scanners with telemedicine platforms represents a significant advancement in veterinary care, offering remote diagnostic services that can greatly enhance access to veterinary expertise. This integration allows veterinarians to analyze imaging results remotely, providing timely consultations and second opinions without the need for pet owners to visit multiple facilities. For pet owners in rural or underserved areas, where access to specialized veterinary services might be limited, this technology ensures that they can receive high-quality diagnostic care without the constraints of geographical boundaries. The ability to transmit high-resolution images from pet scanners to telemedicine platforms facilitates accurate and efficient diagnosis and treatment planning, ultimately leading to better health outcomes for pets.

  Moreover, integrating pet scanners with telemedicine platforms enhances the overall service offerings of veterinary clinics, making them more competitive and responsive to the evolving needs of pet owners. This technology enables veterinary clinics to offer comprehensive care packages that include remote monitoring and follow-up consultations, which are particularly beneficial for managing chronic conditions or postoperative recovery. Additionally, telemedicine-supported diagnostics can improve the efficiency of veterinary practices by reducing the need for in-person visits for routine diagnostic checks, thereby freeing up clinic resources for more complex cases. The combination of pet scanners and telemedicine also allows for the creation of a digital repository of pet health records, which can be easily accessed and shared among veterinary professionals, ensuring continuity of care and fostering collaborative treatment approaches.

Key players in Global Pet Scanners Market include.

• GE Healthcare
• Philips Healthcare
• Siemens Healthcare

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis